Variation Biotechnologies Inc.: federal grants and contributions: 2 agreements; $56.3M value; 2 departments; 2 programs.
Assay record ASY-CA-0YKN1XQ1UO · Cite as: Assay Systems, “Variation Biotechnologies Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/variation-biotechnologies-inc/
This project will support the development of Canada’s medical countermeasures (MCMs) in immediate response to COVID-19. Variation Biotechnologies Inc. (VBI) will advance the development of an enveloped Virus-Like-Particle (eVLP) vaccine candidate through clinical trials to provide protection against SARS-COV2 (COVID-19), MERS and SARS.
Monies allocated over more than one fiscal year; New disclosure of an already published grant or contribution;Repayable Contribution
All grants from Innovation, Science and Economic Development Canada
All grants from Canada Economic Development for Quebec Regions
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.